Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01966432 · ClinicalTrials.gov registry record · NA
Screening, Brief Intervention, and Referral to Treatment in Primary Care
A NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT01966432 is a NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders that has completed, run by Duke University. The registered enrollment target is 134 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01966432, a NA study of Diabetes Mellitus, Type 2 and Substance-Related Disorders, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD)" to explore the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services in Primary Care (SBIRT-PC) and to examine the effects of substance use status on diabetes health care outcomes. This pilot study also examines the feasibility of the CTN's common data element algorithms of SBIRT for illicit and nonmedical drug use in the primary care setting.
Conditions Studied
Interventions
- BEHAVIORAL Brief Intervention
- BEHAVIORAL Referral to Treatment
Study Locations (1)
North Carolina
- Durham County Department of Public Health - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01966432
The ClinicalTrials.gov registry entry for NCT01966432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Brief Intervention is the first listed.
NCT01966432 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01966432 about?
NCT01966432 is a clinical study titled "Screening, Brief Intervention, and Referral to Treatment in Primary Care". This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes ini...
What is the current status of trial NCT01966432?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2013-08. Estimated completion is 2016-06.
What conditions does trial NCT01966432 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Substance-Related Disorders.
What interventions are being tested in trial NCT01966432?
The interventions under investigation include: Brief Intervention (BEHAVIORAL), Referral to Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01966432?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01966432 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Diabetes Mellitus, Type 2
All registered trials for this condition
Substance-Related Disorders
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.